Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277056 · ClinicalTrials.gov registry record
Dysregulated Tyrosine Kinase Signaling in Leukemia
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00277056 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 30 participants.
The verdict
NCT00277056 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Dysregulated Tyrosine Kinase Signaling in Leukemia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277056
The ClinicalTrials.gov registry entry for NCT00277056 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00277056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277056 about?
NCT00277056 is a clinical study titled "Dysregulated Tyrosine Kinase Signaling in Leukemia". Dysregulated Tyrosine Kinase Signaling in Leukemia
What is the current status of trial NCT00277056?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2002-05. Estimated completion is 2005-10.
Who is sponsoring clinical trial NCT00277056?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.